FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1297147001: Product containing balsam of Peru and bismuth oxide and zinc oxide in cutaneous dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Mar 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5290056011 Product containing balsam of Peru and bismuth oxide and zinc oxide in cutaneous dose form (medicinal product form) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
5290057019 Balsam of Peru- and bismuth oxide- and zinc oxide-containing product in cutaneous dose form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing balsam of Peru and bismuth oxide and zinc oxide in cutaneous dose form (medicinal product form) Is a Balsam of Peru- and bismuth oxide- and zinc oxide-containing product true Inferred relationship Some
Product containing balsam of Peru and bismuth oxide and zinc oxide in cutaneous dose form (medicinal product form) Has manufactured dose form Cutaneous dose form true Inferred relationship Some
Product containing balsam of Peru and bismuth oxide and zinc oxide in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Balsam of Peru true Inferred relationship Some 1
Product containing balsam of Peru and bismuth oxide and zinc oxide in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bismuth oxide (substance) true Inferred relationship Some 2
Product containing balsam of Peru and bismuth oxide and zinc oxide in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Zinc oxide true Inferred relationship Some 3
Product containing balsam of Peru and bismuth oxide and zinc oxide in cutaneous dose form (medicinal product form) Is a Zinc oxide-containing product in cutaneous dose form true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Balsam of Peru and bismuth oxide and zinc oxide only product in cutaneous dose form Is a True Product containing balsam of Peru and bismuth oxide and zinc oxide in cutaneous dose form (medicinal product form) Inferred relationship Some

Reference Sets

GB English

US English

Back to Start